Loading clinical trials...
Loading clinical trials...
Catheter-based Transendocardial Delivery of Autologous Bone Marrow-Derived Cells in Patients With Heart Failure Due to Dilated Cardiomyopathy
Conditions
Interventions
Ixmyelocel-T
Vehicle Control
Locations
3
United States
Minneapolis Heart Institute
Minneapolis, Minnesota, United States
University Hospitals, Case Western Reserve University
Cleveland, Ohio, United States
University of Utah
Salt Lake City, Utah, United States
Start Date
December 1, 2009
Primary Completion Date
January 11, 2012
Completion Date
December 5, 2013
Last Updated
May 27, 2021
NCT07359690
NCT07354646
NCT04638621
NCT06688396
NCT06356727
NCT06055504
Lead Sponsor
Vericel Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions